In order to identify the fundamental physical determinants of these receptor functions, and to determine which properties are unique to a particular receptor, or are universal to all receptors, biochemical characterization of both peripheral and central nervous system receptors is necessary. Since the original biochemical description of the properties of post-synaptic receptors in the central nervous system [1] , most attention has turned to cholinergic receptors found at the vertebrate neuromuscular junction and in electric organ, and an extensive literature on biochemical and physiological characterizations of peripheral nicotinic acetylcholine receptors {nAChR) has [2] and continues to develop. Concurrently, with the utilization of radiolabeled stereospecific and natural ligands [3] [4] [5] , putative central nervous systems {CNS) neurotransmitter receptor entities began to be characterized. Toward identification of a CNS nAChR, reports from this [6] and other laborato~ies [7] [8] [9] [10] [11] [12] [13] have appeared describing the specificity of krait a-toxin binding to particulate and detergent-solubilized fractions derived from mammalian brain. However, other than the abiiity of cholinergic drugs to prevent a-toxin binding, which might be expected on the basis of their comparable structural features alone, there has appeared no demonstration of active responsiveness of the a-toxin binding entity derived from mammali.an brain to cholineric ligands.
Reported here are the characteristics of a membrane-bound entity from rat brain capable of high-affinity, specific interaction with the post-synaptic toxin from Bungarus multicinctus, a-bungarotoxin (a-Bgt).
Insensitivity of this interaction to non-specific ionic strength effects is described, as well as a partial characterization of alteration in receptor binding properties on exposure to cholinergic ligands, and selectivity of that response to agonists. A summary report of these results was presented at the annual meeting of the American Society for Neurochemistry, Washington, D.C., March, 1978 [14] .
METHODS
Procedures for purification of a-Bgt from crude lyophilized venom non-specifically bound radioactivity is determined by filtration of -ammoniumsulfate treated samples on Millipore HAWP filter discs [17] or by the Whatman DE81 filter disc method [18] with comparable results. Non-specific adsorption of radiolabeled toxin to filters is negligible given the small quantities of free toxin in these experiments. In all cases, material balance of bound radioactivity is within 10% of control values for CMF treated in the absence of detergent. Assays for a-Bgt binding to Triton X-100 solubilized CMF is as described above, except that filter disc methods f17, 18] are substituted for wash procedures. For these assays, the cold chase protocol is particularly useful to minimize non-specific adsorbtion of radiolabeled toxin to filter discs. The most consistent results were obtained using a single disc per assay rather than a stack of two discs; criteria for accuracy and consistency of filtration assay results is the extent of agreement with results obtained on duplicate samples using more tedious gel filtration or ion-exchange column chromatography techniques.
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• Other Methods
Membrane proteins were determined by conventional, and solubilized proteins by modified Lowry [19] techniques, using protein standards made in the presence of detergent.
Acetylcholine perchlorate was synthesized in our laboratory. Other chemicals and reagents were Tris, PMFS, NaN 3 , Triton X-100, carbamyl- Table III . While preincubation with antagonist has little or no effect on the formation of CMF membrane-a-Bgt complexes at .
equi 1 ibri urn, pretreatment with agonist results in an apparent increase in the affinity of CMF membrane for agonist. Moreover, this potentiation effect is most evident for the natural ligand, acetylcholine, which apparently ·binds with forty-fold more tenacity on preincubation than on coincubation;
the increase in its apparent affinity for CMF membrane sites is nearly an order of magnitude larger than that seen· for artificial cholinergic agonists.
In view of the interest in the ultimate purification of the a-Bgt binding entity characterized above, preliminary experiments were performed using non-ionic detergents to solubilize specific a-Bgt-CMF complexes. As summarized in Table IV, to other reports where 200m!i NaCl is used to terminate or prevent "specific" a-Bgt binding to whole brain homogenates r12] and where marked ionic-strength sensitivity of a-Bgt binding to brain crude mitocho~drial fractions is described [7] . In the latter report, the variation of binding with ionic strength closely resembles the variation of total (non-specific plus specific) binding reported here. [26, 27] and in CNS synaptic structures [28] , the response of known CNS cholinergic neurons to acetylcholine was found not to be blocked by a-Bgt [29, 30] , suggesting that a-Bgt binding sites in the CNS might be no more than a curiosity with respect to physiological function. In contrast, Torpedo nAChR shows conditioning effects in response to both agonist and antagonist [31] . Furthermore, the observation that all specific a-Bgt binding sites in the CNS may be displaced by both agoni-st and antagonist • ..
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. HAWP or directly on Whatman DE8I discs. In no case was the recovery of specific Assays in 46m~ NaCl, 2m~ KCl, 0.72m~ CaC1 2 , 0.53m~ MgS0 4 , 13.2m~ Tris base, pH 7.4 with HCl, 1 mg/ml albumin, 1 mg/ml CMF protein, 10 
